Levitra Bayer — Research Summary
Vardenafil HCl is a phosphodiesterase type 5 (PDE5) inhibitor that serves as a valuable research compound for investigating vascular physiology and cellular signaling mechanisms. This selective enzyme inhibitor demonstrates high specificity for PDE5 compared to other phosphodiesterase isoforms, making it an essential tool for researchers examining cyclic guanosine monophosphate (cGMP) pathways. Scientists at Stroid UK Shop utilize this compound to study nitric oxide-mediated vascular responses and endothelial function in controlled laboratory environments.
Laboratory Applications
Research teams investigate vardenafil HCl for its potent inhibitory effects on PDE5 enzyme activity, which plays a crucial role in smooth muscle relaxation mechanisms. Studies examine its selectivity profile against various phosphodiesterase subtypes, particularly its enhanced specificity compared to sildenafil analogues. Researchers exploring vardenafil compounds analyze its pharmacokinetic properties, including oral bioavailability and metabolic pathways. Laboratory investigations focus on its interaction with guanylate cyclase systems and downstream cellular responses. Scientists studying cardiovascular research may also explore compounds from our SARMs collection or peptide research tools for comprehensive vascular biology studies.
Technical Specifications
| CAS Registry | 224785-91-5 |
|---|---|
| Molecular Formula | C₂₃H₃₂N₆O₄S·HCl |
| Molecular Weight | 525.07 g/mol |
| Purity | Contact supplier for verification |
| Storage | Room temperature, dry conditions |
| Solubility | DMSO, ethanol (verify protocols) |
Research Compliance
This vardenafil HCl is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure proper handling protocols and laboratory safety measures when conducting studies with this PDE5 inhibitor compound.
